Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C De Salvo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chest|December 1, 1981
Liver alterations in antituberculosis regimens containing pyrazinamideJ A Pilheu, M C De Salvo, O Koch
Medicina|September 21, 2001
[Physiopathology, diagnosis and treatment of severe chronic hypoxemia. Role of residential chronic oxygen therapy]J O Cáneva, C A Rabec, M C De Salvo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 24, 1998
CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infectionJ A Pilheu, M C De Salvo, J Gonzalez, et al.
Chest|May 12, 2001
In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter studyA D D'Urzo, M C De Salvo, A Ramirez-Rivera, et al.
Drug Research|April 6, 2013
Non-inferiority trial between two dry-powder inhalers containing fluticasone/salmeterol in asthmatic patientsH A Serra, F P Klapouszko, M C De Salvo, et al.
Respiratory Medicine|February 23, 2010
Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDIR Zuwallack, M C De Salvo, T Kaelin, et al.
Medicina|January 1, 1989
[Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin]J A Pilheu, M R Galati, A S Yunis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chest|December 1, 1981
Liver alterations in antituberculosis regimens containing pyrazinamideJ A Pilheu, M C De Salvo, O Koch
Medicina|September 21, 2001
[Physiopathology, diagnosis and treatment of severe chronic hypoxemia. Role of residential chronic oxygen therapy]J O Cáneva, C A Rabec, M C De Salvo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 24, 1998
CD4+ T-lymphocytopenia in severe pulmonary tuberculosis without evidence of human immunodeficiency virus infectionJ A Pilheu, M C De Salvo, J Gonzalez, et al.
Chest|May 12, 2001
In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter studyA D D'Urzo, M C De Salvo, A Ramirez-Rivera, et al.
Drug Research|April 6, 2013
Non-inferiority trial between two dry-powder inhalers containing fluticasone/salmeterol in asthmatic patientsH A Serra, F P Klapouszko, M C De Salvo, et al.
Respiratory Medicine|February 23, 2010
Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDIR Zuwallack, M C De Salvo, T Kaelin, et al.
Medicina|January 1, 1989
[Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin]J A Pilheu, M R Galati, A S Yunis, et al.
Pageof 1